Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Pau
Clinical trial register · France

Clinical Trials in Pau, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Pau

26 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Centre Hospitalier de PAU
Not applicable
280
Pau
2027-03-01
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Bron, Corbeil-Essonnes, La Tronche, Le Coudray, Lens, Metz-Tessy, Pau, Rennes
2026-08-24
Not yet open
University Hospital, Limoges
Not applicable
85
Limoges, Pau
2026-06-15
Recruiting
French Cardiology Society
Not applicable
250
Chambray-lès-Tours, Lyon, Pau, Pessac, Saint-Denis, Strasbourg, Toulouse
2026-06-02
Recruiting
Impact of Endotest on Patients' Quality of Life: a Cohort Study
NCT07560852Patient With a Prescribed Endotest, Endometriosis (Diagnosis)
ZIWIG
Observational
20,000
Bordeaux, Saint-Grégoire, Lorient, Peltre, Saint-Priest-en-Jarez, Pau, Montivilliers
2026-05-06
Active, closed
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc.
Phase 3
540
Le Kremlin-Bicêtre, Montpellier, Nantes, Nice, Pau, Poitiers
2026-03-03
Recruiting
University of Rochester
Not applicable
62
Pau, Chambray-lès-Tours, Pessac
2026-01-22
Recruiting
AstraZeneca
Phase 3
1,100
Amiens, Avignon, Nîmes, Paris, Pau, Pierre-Bénite, Plerin SUR MER, Reims
2025-12-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Marseille, Caen, Vandœuvre-lès-Nancy, Pau, Chambéry, Amiens, Paris
2025-10-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Auxerre, Bobigny, Bordeaux, Caen, Nîmes, Paris, Pau, Poitiers
2025-09-06
Recruiting
Sanofi
Phase 3
723
Bron, La Tronche, Lille, Paris, Pau, Strasbourg
2025-08-06
Recruiting
Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome
NCT06889974Renal Replacement Therapy for Acute Kidney Injury in ICU
University Hospital, Bordeaux
Observational
800
Angers, Bordeaux, Brest, Limoges, Nantes, Orléans, Pau, Rennes
2025-07-01
Recruiting
Ventricular Arrhythmias in Acute Myocardial Infarction
NCT07517523Ventricular Arrhythmia, Acute Myocardial Infarction (AMI)
Poitiers University Hospital
Observational
500
Caen, Dijon, Grenoble, Paris, Pau, Poitiers, Saint-Etienne, Tours
2025-06-20
Recruiting
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
NCT06128343Adenocarcinoma, Carcinoma, Neoplasms
University Hospital, Toulouse
Observational
1,500
Béthune, Bordeaux, Lille, Lyon, Montpellier, Pau, Toulouse
2023-11-16
Recruiting
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
NCT06014112Acute Coronary Syndrome, Continuous Glucose Measurement, Glycemic Variability, Cardiovascular Event
University Hospital, Montpellier
Not applicable
850
Béziers, Bordeaux, Montpellier, Nîmes, Paris, Pau, Toulouse, Vannes
2023-11-06
Active, closed
AstraZeneca
Phase 2
194
Bobigny, Boulogne-Billancourt, Marseille, Paris, Pau, Pierre-Bénite, Poitiers, Vandœuvre-lès-Nancy
2022-08-11
Recruiting
University Hospital, Bordeaux
Phase 2/3
90
Bayonne, Bordeaux, Brest, Grenoble, Libourne, Mont-de-Marsan, Paris, Pau
2022-06-22
Active, closed
AstraZeneca
Phase 3
791
Aix-en-Provence, Angers, Bobigny, Lille, Paris, Pau, Quimper, Saint-Grégoire
2022-02-18
Recruiting
The "Global Paradise System" Registry
NCT05027685Hypertension
ReCor Medical, Inc.
Observational
3,000
Grenoble, Bordeaux, Marseille, Paris, Pau
2022-01-13
Active, closed
Centre Hospitalier de PAU
Phase 4
500
Aix-en-Provence, Chartres, Haguenau, La Rochelle, Libourne, Metz-Tessy, Pau, Périgueux
2021-08-03
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
La Rochelle, Massy, Nîmes, Paris, Pau, Rouen
2021-05-15
Recruiting
Boston Scientific Corporation
Observational
12,500
Brest, Clermont-Ferrand, Lomme, Pau, Saint-Etienne
2021-03-31
Active, closed
Provention Bio, a Sanofi Company
Observational
188
Orléans, Bron, Dijon, Marseille, Nice, Paris, Pau
2020-10-26
Active, closed
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NCT04258137Colorectal Cancer, Non Small Cell Lung Cancer
Institut Bergonié
Not applicable
332
Bayonne, Bordeaux, Brest, Pau
2020-09-04
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Recruiting
Institut Bergonié
Not applicable
10,000
Bayonne, Bordeaux, Pau, Rennes
2015-12
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/pau

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Pau.

How many clinical trials are recruiting in Pau?

16 of the 26 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pau), 26 studies
PhaseStudiesRecruitingShare
Not applicable8430.8%
Phase 38530.8%
Observational7626.9%
Phase 2103.8%
Phase 2/3113.8%
Phase 4103.8%

Most active sponsors

Lead sponsors with the most studies (Pau)
Lead sponsorStudiesRecruiting
AstraZeneca42
Centre Hospitalier de PAU20
Institut Bergonié21
University Hospital, Bordeaux22
Alnylam Pharmaceuticals11
Boston Scientific Corporation11
Eli Lilly and Company10
French Cardiology Society11
M.A. Med Alliance S.A.10
Merck Sharp & Dohme LLC11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.